\-\ Texto\\:\\ \ \(0\)\
\-\ mild\\ hypertension\\.\ \(0\)\
\-\ complex\\,\\ round\\,\\ heterogeneously\\ enhancing\\ mass\\ measuring\\ approximately\\ 5\\.5\\ x\\ 5\\.5\\ cm\\ and\\ positioned\\ anterior\\ to\\ the\\ ivc\\ and\\ inferior\\ to\\ the\\ third\\ portion\\ of\\ the\\ duodenum\\.\ \(0\)\
\-\ extra\\ adrenal\\ pheochromocytoma\\ \\(paraganglioma\\)\ \(0\)\
\-\ retroperitoneal\\ sarcoma\ \(0\)\
\-\ lymphoma\ \(373\)\
\-\ solitary\\ enlarged\\ lymph\\ node\ \(0\)\
\-\ smooth\\ muscle\\ tumor\\ associated\\ with\\ duodenum\ \(0\)\
\-\ 66\\ yo\\ male\\ presents\\ to\\ urology\\ service\\ with\\ history\\ of\\ hematuria\\ and\\ pyelonephritis\\.\ \(0\)\
\-\ during\\ surgical\\ resection\\,\\ the\\ patient\\ became\\ hypertensive\\ as\\ the\\ mass\\ was\\ manipulated\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ 5\\.5\\:\\ 0\\.1473363582382913\ \(0\)\
\-\ duodenum\\:\\ 0\\.11711047296050815\ \(0\)\
\-\ manipulated\\:\\ 0\\.09404081092210896\ \(0\)\
\-\ pheochromocytoma\\:\\ 0\\.06986938680964772\ \(0\)\
\-\ extra\\:\\ 0\\.06771876609071863\ \(0\)\
\-\ paraganglioma\\:\\ 0\\.06695136581456122\ \(0\)\
\-\ urology\\:\\ 0\\.06695136581456122\ \(0\)\
\-\ positioned\\:\\ 0\\.0662278415887391\ \(0\)\
\-\ hypertensive\\:\\ 0\\.06397871276294854\ \(0\)\
\-\ heterogeneously\\:\\ 0\\.06368770620314224\ \(0\)\
\-\ pyelonephritis\\:\\ 0\\.06312502566427093\ \(0\)\
\-\ service\\:\\ 0\\.06258629636783047\ \(0\)\
\-\ became\\:\\ 0\\.05836488360222193\ \(0\)\
\-\ 66\\:\\ 0\\.05817735087076445\ \(0\)\
\-\ ivc\\:\\ 0\\.05763086768259725\ \(0\)\
\-\ retroperitoneal\\:\\ 0\\.05763086768259725\ \(0\)\
\-\ adrenal\\:\\ 0\\.05477065891435897\ \(0\)\
\-\ solitary\\:\\ 0\\.0536811069045964\ \(0\)\
\-\ hematuria\\:\\ 0\\.05130815809074357\ \(0\)\
\-\ node\\:\\ 0\\.04949675500668441\ \(0\)\
\-\ sarcoma\\:\\ 0\\.048163077593294204\ \(0\)\
\-\ smooth\\:\\ 0\\.04734613428775533\ \(0\)\
\-\ round\\:\\ 0\\.04672853727295239\ \(0\)\
\-\ lymph\\:\\ 0\\.04366509378410945\ \(0\)\
\-\ third\\:\\ 0\\.043372742963924016\ \(0\)\
\-\ complex\\:\\ 0\\.04331507440017895\ \(0\)\
\-\ measuring\\:\\ 0\\.043257667372768926\ \(0\)\
\-\ hypertension\\:\\ 0\\.042642798130382124\ \(0\)\
\-\ portion\\:\\ 0\\.03917983097922894\ \(0\)\
\-\ muscle\\:\\ 0\\.0388520915623588\ \(0\)\
\-\ enlarged\\:\\ 0\\.03690659582764565\ \(0\)\
\-\ inferior\\:\\ 0\\.03670020710581092\ \(0\)\
\-\ x\\:\\ 0\\.03568438399174022\ \(0\)\
\-\ enhancing\\:\\ 0\\.03392346244157923\ \(0\)\
\-\ resection\\:\\ 0\\.033733109563547074\ \(0\)\
\-\ approximately\\:\\ 0\\.033466048437412445\ \(0\)\
\-\ during\\:\\ 0\\.03310138291042795\ \(0\)\
\-\ yo\\:\\ 0\\.03254875345952863\ \(0\)\
\-\ lymphoma\\:\\ 0\\.03091390676442387\ \(0\)\
\-\ mass\\:\\ 0\\.030087620429052265\ \(0\)\
\-\ cm\\:\\ 0\\.029012102757177034\ \(0\)\
\-\ mild\\:\\ 0\\.028484220935837176\ \(0\)\
\-\ anterior\\:\\ 0\\.027858137009654903\ \(0\)\
\-\ associated\\:\\ 0\\.025524842555793695\ \(0\)\
\-\ tumor\\:\\ 0\\.02521813040013685\ \(0\)\
\-\ surgical\\:\\ 0\\.022736984433562705\ \(0\)\
\-\ presents\\:\\ 0\\.022096763234277544\ \(0\)\
\-\ male\\:\\ 0\\.019559563770727508\ \(0\)\
\-\ as\\:\\ 0\\.016361740580938325\ \(0\)\
\-\ to\\:\\ 0\\.01621777626998682\ \(0\)\
\-\ history\\:\\ 0\\.014939424527937764\ \(0\)\
\-\ was\\:\\ 0\\.012509842053337808\ \(0\)\
\-\ patient\\:\\ 0\\.010842935834384658\ \(0\)\
\-\ \\,\\:\\ 0\\.010280129070276737\ \(0\)\
\-\ \\(\\:\\ 0\\.009143819319542537\ \(0\)\
\-\ \\)\\:\\ 0\\.009032122684978544\ \(0\)\
\-\ the\\:\\ 0\\.008749954728077583\ \(0\)\
\-\ and\\:\\ 0\\.006835785027805764\ \(0\)\
\-\ with\\:\\ 0\\.002962131040250373\ \(0\)\
\-\ of\\:\\ 0\\.0029494633113414793\ \(0\)\
\-\ \\.\\:\\ 0\\.001797444865688419\ \(0\)\
